Advertisements


Decoding cancer: Hopes rise for a new age of precision medicine

Treatments targeting the molecular features of a tumor could usurp chemotherapy — but at a price......»»

Category: topSource: bizjournalsOct 13th, 2017

Precision medicine startup Syapse raises $30 million to expand cancer tech, S.F. workforce

San Francisco-based Syapse today raised $30 million in Series D funding to expand operations for its precision medicine software. This brings its total funding to about $71 million since launching in 2008. Syapse is seeing fast growth as more hea.....»»

Category: topSource: bizjournalsNov 14th, 2017

What they said: Leaders in precision medicine set hopes on future advancements

Leaders in precision medicine set hopes on future advancements.....»»

Category: topSource: bizjournalsSep 1st, 2017

What happened to precision medicine?

Precision medicine isn't being used for all cancer patients — yet.....»»

Category: topSource: bizjournalsSep 1st, 2017

Novartis Profit Dented by Investment in New Drugs

Novartis said profit fell in the first quarter as it pumped investment into the launch of its new heart-failure drug Entresto that it hopes will help offset revenue lost as best-selling cancer medicine Gleevec loses out to cheaper competitors......»»

Category: smallbizSource: wsjApr 25th, 2017

UCSF"s $275M cancer center set to break ground in Mission Bay next month

The $275 million UC San Francisco Precision Cancer Medicine Building will break ground next month, the latest project approved in the university’s massive Mission Bay expansion. Construction on the 170,000-square-foot facility located on the Sout.....»»

Category: topSource: bizjournalsMar 15th, 2017

How Precision Medicine Could Be A Lifesaver For Kids With Brain Cancer

N.....»»

Category: smallbizSource: forbesJan 19th, 2017

SAPVoice: Precision Medicine Gives People With Cancer New Hope In 2017

When it comes to something as deeply personal and emotionally powerful as a cancer diagnosis, few people are satisfied with a one-size-fits-all treatment plan. Welcome to the next phase of prec.....»»

Category: smallbizSource: forbesJan 18th, 2017

Drug costs skyrocket for many older Americans, despite Medicare coverage

To avoid liver damage, Roberta Solar, a 71-year-old cancer patient, has to take a medicine called ursodiol, perhaps for the rest of her life. Next year her annual out-of-pocket costs for the drug will jump from $93 to $1,878 – a rise of almost 2,000%, a.....»»

Category: topSource: latimesNov 23rd, 2016

Bitcoin futures suggest cryptocurrency"s blistering price rise to slow

Although there are hopes that the futures will draw in new investors, most fund managers at larger asset managers and institutional investors said bitcoin remains too volatile.....»»

Category: topSource: business-standardDec 11th, 2017

Global stocks mostly rise on economic growth hopes

Share prices were higher in Asia on Monday, lifted by encouraging employment data from the U.S. that took the Standard & Poor's 500 index to its third straight weekly gain on Friday despite weakness earlier in the week......»»

Category: topSource: foxnewsDec 11th, 2017

With Disney-Fox Talks, Hopes Rise for a Greenlight on Sky

If Disney or another suitor buy 21st Century Fox’s international assets, investors are betting U.K. regulators will allow the full acquisition of pay-TV operator Sky......»»

Category: smallbizSource: wsjDec 8th, 2017

Amid Shift To Electric Vehicles, Analyst Looks For BorgWarner To Benefit

Not every auto supplier will survive the rise of electric. But BorgWarner Inc. (NYSE: BWA) hopes to ride the current — and Oppenheimer said it’s situated to do do. La.....»»

Category: blogSource: benzingaDec 7th, 2017

IEA"s view out of touch, thermal coal demand won"t rise beyond 10%: Report

India's thermal coal demand is poised to fall, belying hopes of exporters from Australia and US who eyed the country as a long-term growth market.The country is now the second largest consumer cum importer of thermal coal but i.....»»

Category: topSource: business-standardNov 29th, 2017

Tea stocks surge on hopes of higher realisations as prices rise

After a period of prolonged uncertainty in tea producing companies, optimism suddenly seems to have returned in the industry as the scrips of tea producing firms rallied on the Bombay Stock Exchange today with hopes of the balance s.....»»

Category: topSource: business-standardNov 21st, 2017

Europe approves GlaxoSmithKline"s new triple lung drug

Europe has approved GlaxoSmithKline's new three-in-one inhaler for chronic lung disease, which the group hopes will help it keep its lead in respiratory medicine despite falling sales of older drug Advair......»»

Category: topSource: foxnewsNov 16th, 2017

Caterpillar October Sales Rise 19%: Machinery Stocks in Focus

Caterpillar (CAT) manages to make a comeback on improvement in end markets and disciplined cost control. This raises hopes for investors focused on machinery stocks. Caterpillar Inc. CAT reported a 19% rise in g.....»»

Category: topSource: zacksNov 14th, 2017

Foxconn revenues rise 2.87% on year in October

Foxconn Electronics (Hon Hai Precision Industry) has reported consolidated revenues of NT$485.458 billion (US$16.09 billion) for October 2017, representing a 7.63% increase on month and 2.87% increase on year......»»

Category: topSource: digitimesNov 13th, 2017

The rise of the petro-yuan

REUTERS/Jason Lee China is aiming to overthrow the U.S. dollar as the currency of choice for the oil market, a move that could have far-reaching consequences. Beijing hopes to challenge the dollar by setting up a futures mark.....»»

Category: topSource: businessinsiderOct 29th, 2017

Swiss drugs maker Novartis reports 7 percent rise in 3Q net

Swiss pharmaceuticals company Novartis is reporting net income rose 7 percent in the third quarter behind growth for its psoriasis treatment Cosentyx, its eye care business and several cancer drugs......»»

Category: topSource: foxnewsOct 24th, 2017

A cancer treatment that"s part of "a big new field of medicine" just got approved (GILD)

Wikimedia CommonsThe FDA just approved another revolutionary cancer treatment.  The treatment, called Yescarta.....»»

Category: topSource: businessinsiderOct 18th, 2017